Related Experiment Video
Updated: Aug 22, 2026
Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
CXCL12/CXCR4 signaling governs ischemic neurovascular pathophysiology and repair: a multidimensional contextual
Shahram Eisa-Beygi1, Hao Wu1, Kui Cui1
1Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, MA, 02115, USA.
Insights
The CXCL12/CXCR4 axis plays a dual role in ischemic stroke recovery, initially causing damage but later promoting repair. Understanding its complex timing and cell-type specific actions is key for developing new stroke therapies.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Ischemic stroke is a major global health issue requiring effective treatments.
- The CXCL12 signaling pathway and its receptor CXCR4 are critical in the brain after stroke.
- Their roles change over time, impacting both damage and healing processes.
Purpose of the Study:
- To review the complex, context-dependent roles of the CXCL12/CXCR4 axis in the post-ischemic brain.
- To explore how this axis influences pathological and restorative processes.
- To evaluate the therapeutic potential and challenges of targeting this axis for stroke recovery.
Main Methods:
- Literature review synthesizing mechanistic data and translational insights.
- Analysis of the temporal duality of CXCL12/CXCR4 signaling in the neurovascular lesion.
- Examination of interactions with distinct CXCL12 isoforms, ACKR3/CXCR7, and non-pharmacological interventions.
Main Results:
- The CXCL12/CXCR4 axis has a temporal duality, contributing to acute damage (e.g., BBB disruption) and later promoting repair (neurogenesis, angiogenesis, remyelination).
- Distinct CXCL12 isoforms and the receptor ACKR3/CXCR7 modulate these effects.
- Endogenous repair mechanisms involving this axis synergize with interventions like environmental enrichment.
Conclusions:
- The functional outcome of CXCL12/CXCR4 signaling depends on timing, cell type, receptor availability, and adaptive responses.
- Targeting the CXCL12/CXCR4 axis offers therapeutic potential for ischemic stroke.
- Overcoming pharmacological barriers is crucial for future regenerative strategies.
Abstract:
Ischemic stroke is a global health crisis necessitating targeted therapeutic strategies. Central to post-stroke pathology and repair is the CXCL12 signaling axis. In this review, we discuss the context-dependent roles of CXCL12 and its canonical receptor, CXCR4, within the post-ischemic microenvironment. The CXCL12/CXCR4 axis exhibits a temporal duality across the evolution of the neurovascular lesion; however, current evidence necessitates moving beyond a strictly binary framework. While the acute phase involves pathological cascades, such as blood-brain barrier disruption and leukocyte infiltration, the axis is simultaneously essential for recruiting protective innate immune subsets. During subsequent subacute and chronic phases, it governs essential restorative processes, including neurogenesis, angiogenesis, and remyelination. This complex temporal shift is mediated by the interplay between distinct CXCL12 isoforms and the regulatory influence of the atypical receptor ACKR3/CXCR7. Furthermore, these endogenous repair mechanisms exhibit synergies with non-pharmacological interventions, notably environmental enrichment and remote ischemic postconditioning. Our multidimensional model suggests that the functional outcome of CXCL12/CXCR4 signaling is determined by the intersection of timing, cell type, receptor availability, and adaptive responses to physiological stimuli. We synthesize fundamental mechanistic data with translational insights to evaluate the therapeutic potential of this axis and the pharmacological barriers to future regenerative strategies.
